000231 USING MRS (MAGNETIC RESONANCE SPECTROSCOPY) FOR PHARMACOKINETICS OF CISPLATIN GIVEN AT A DAILY LOW DOSE AS A RADIOSENSITISER IN HUMAN CERVICAL CANCER TUMOURS. (1st September 2005)